Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: Real-world study of 18 million patients in four European cohorts. Alexander, M., Loomis, A. K., Van Der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., Rijnbeek, P., Mosseveld, M., Waterworth, D. M., Kendrick, S., Sattar, N., & Alazawi, W. BMC Medicine, 2019.
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: Real-world study of 18 million patients in four European cohorts [link]Paper  bibtex   
@article{RN256,
   author = {Alexander, M. and Loomis, A. K. and Van Der Lei, J. and Duarte-Salles, T. and Prieto-Alhambra, D. and Ansell, D. and Pasqua, A. and Lapi, F. and Rijnbeek, P. and Mosseveld, M. and Waterworth, D. M. and Kendrick, S. and Sattar, N. and Alazawi, W.},
   title = {Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: Real-world study of 18 million patients in four European cohorts},
   journal = {BMC Medicine},
   volume = {17},
   number = {1 , DOI = 10.1186/s12916-019-1321-x},
   url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065878944&doi=10.1186%2fs12916-019-1321-x&partnerID=40&md5=a05608b81e8f78fcd5d8c38aba2b5f47https://bmcmedicine.biomedcentral.com/track/pdf/10.1186/s12916-019-1321-x},
   year = {2019},
   type = {Journal Article}
}

Downloads: 0